Use of imiquimod topical therapy for management of malignant melanoma positive margins
The use of 5% topical imiquimod therapy is a safe, cost-effective, and reasonable alternative approach in the management of positive surgical margins. The degree of inflammation around the site of disease may be used as a reliable predictor of outcome.
Authors
- James Clune (ORCID: https://orcid.org/0000-0002-2398-4634)
- Katelyn Lewis
- Kelly Olino (ORCID: https://orcid.org/0000-0001-6209-5218)
- David P. Alper
- Stephan Ariyan
- Jonathan S. Leventhal (ORCID: https://orcid.org/0000-0002-3757-8477)
- Jennifer Nam Choi (ORCID: https://orcid.org/0000-0003-4897-3277)
- Raymond P. Baumann
- Sara Islam (ORCID: https://orcid.org/0000-0003-1670-7767)
- Martin J. Carney
Institutions
- Northwestern University (US)
- Yale Cancer Center (US)
- Yale University (US)
- University of Mississippi (US)
- University of Rochester (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-29
- DOI
- https://doi.org/10.3389/fonc.2025.1666463
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00